Financial Snapshot

Revenue
$20.00K
TTM
Gross Margin
100.0%
TTM
Net Earnings
-$1.184M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
0.59%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$9.867M
Q3 2024
Cash
Q3 2024
P/E
-2.271
Nov 27, 2024 EST
Free Cash Flow
-$53.45K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $20.00K $279.3K $663.4K $275.6K $43.17K $69.35K $629.0K $108.9K $174.6K $54.92K $70.00K $270.0K $180.0K $230.0K $290.0K $770.0K $780.0K
YoY Change -92.84% -57.9% 140.76% 538.31% -37.75% -88.98% 477.67% -37.65% 217.99% -21.54% -74.07% 50.0% -21.74% -20.69% -62.34% -1.28%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $20.00K $279.3K $663.4K $275.6K $43.17K $69.35K $629.0K $108.9K $174.6K $54.92K $70.00K $270.0K $180.0K $230.0K $290.0K $770.0K $780.0K
Cost Of Revenue $4.808K $3.300K $17.55K $20.70K $42.31K $37.06K $56.90K $26.49K $0.00 $0.00 $0.00 $20.00K $50.00K $20.00K $140.0K
Gross Profit $20.00K $274.5K $660.1K $275.6K $25.62K $48.65K $586.7K $71.83K $117.7K $28.43K $60.00K $270.0K $180.0K $210.0K $240.0K $750.0K $640.0K
Gross Profit Margin 100.0% 98.28% 99.5% 100.0% 59.35% 70.15% 93.27% 65.97% 67.42% 51.77% 85.71% 100.0% 100.0% 91.3% 82.76% 97.4% 82.05%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Selling, General & Admin $491.6K $494.2K $454.1K $497.2K $525.8K $607.6K $896.5K $855.9K $1.140M $1.154M $790.0K $1.540M $1.350M $970.0K $1.610M $2.070M $1.980M
YoY Change -0.52% 8.82% -8.67% -5.44% -13.47% -32.22% 4.74% -24.94% -1.21% 46.11% -48.7% 14.07% 39.18% -39.75% -22.22% 4.55%
% of Gross Profit 2458.02% 180.04% 68.79% 180.43% 2052.22% 1248.94% 152.79% 1191.55% 968.47% 4059.97% 1316.67% 570.37% 750.0% 461.9% 670.83% 276.0% 309.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.77K $18.74K $17.94K $32.02K $39.62K $38.97K $54.42K $57.65K $58.01K $40.42K $40.00K $50.00K $60.00K $40.00K $30.00K $20.00K $20.00K
YoY Change 0.16% 4.46% -43.97% -19.18% 1.67% -28.39% -5.6% -0.62% 43.52% 1.05% -20.0% -16.67% 50.0% 33.33% 50.0% 0.0%
% of Gross Profit 93.85% 6.83% 2.72% 11.62% 154.64% 80.1% 9.28% 80.26% 49.27% 142.17% 66.67% 18.52% 33.33% 19.05% 12.5% 2.67% 3.13%
Operating Expenses $510.4K $512.9K $472.0K $529.2K $565.4K $646.6K $950.9K $913.5K $1.198M $1.195M $820.0K $1.590M $1.400M $1.010M $1.640M $2.090M $2.000M
YoY Change -0.5% 8.66% -10.8% -6.4% -12.56% -32.0% 4.09% -23.76% 0.3% 45.69% -48.43% 13.57% 38.61% -38.41% -21.53% 4.5%
Operating Profit -$490.4K -$238.4K $188.1K -$253.7K -$539.8K -$597.9K -$364.2K -$841.7K -$1.081M -$1.166M -$760.0K -$1.320M -$1.220M -$800.0K -$1.400M -$1.340M -$1.360M
YoY Change 105.67% -226.77% -174.15% -53.01% -9.73% 64.19% -56.74% -22.1% -7.35% 53.45% -42.42% 8.2% 52.5% -42.86% 4.48% -1.47%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Interest Expense $1.887M $1.163M -$1.371M -$1.194M -$1.005M -$1.035M -$1.568M -$1.269M -$915.2K -$755.5K -$590.0K -$170.0K -$130.0K -$270.0K -$360.0K -$300.0K -$240.0K
YoY Change 62.28% -184.85% 14.79% 18.83% -2.92% -33.98% 23.58% 38.6% 21.14% 28.05% 247.06% 30.77% -51.85% -25.0% 20.0% 25.0%
% of Operating Profit -728.69%
Other Income/Expense, Net $1.892M $986.5K $1.261M $0.00 $15.40K $4.810K $4.810K $10.00 $30.00 $300.00 $0.00 $30.00K $0.00 $10.00K
YoY Change 91.8% -21.76% -100.0% 220.17% 0.0% 48000.0% -66.67% -90.0% -100.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Pretax Income -$2.382M -$1.225M -$1.073M -$1.448M -$1.702M $158.3K -$1.827M -$2.051M -$1.990M -$1.926M -$1.340M -$1.450M -$1.360M -$1.070M -$1.750M -$1.640M -$1.610M
YoY Change 94.5% 14.18% -25.9% -14.95% -1174.98% -108.67% -10.92% 3.05% 3.32% 43.76% -7.59% 6.62% 27.1% -38.86% 6.71% 1.86%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.382M -$1.225M -$1.073M -$1.448M -$1.702M $158.3K -$1.827M -$2.051M -$1.990M -$1.926M -$1.340M -$1.450M -$1.360M -$1.070M -$1.750M -$1.640M -$1.610M
YoY Change 94.5% 14.18% -25.9% -14.95% -1174.98% -108.67% -10.92% 3.05% 3.32% 43.76% -7.59% 6.62% 27.1% -38.86% 6.71% 1.86%
Net Earnings / Revenue -11912.2% -438.56% -161.7% -525.33% -3942.85% 228.32% -290.42% -1883.41% -1139.61% -3507.52% -1914.29% -537.04% -755.56% -465.22% -603.45% -212.99% -206.41%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.52 -$0.27 -$236.3K -$322.2K -$565.7K $55.14K -$702.0K -$865.5K -$873.2K -$864.6K -$606.3K -$668.2K -$670.0K -$594.4K -$983.1K -$1.058M -$1.220M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Cash & Short-Term Investments $890.00 $81.38K $66.04K $35.90K $1.300K $2.480K $23.32K $3.020K $0.00 $196.6K $510.0K $450.0K $0.00 $0.00 $30.00K $10.00K $60.00K
YoY Change -98.91% 23.23% 83.96% 2661.54% -47.58% -89.37% 672.19% -100.0% -61.45% 13.33% -100.0% 200.0% -83.33%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $7.980K $9.500K $8.130K $6.500K $4.880K $12.00K $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $0.00 $240.0K $300.0K
YoY Change -16.0% 16.85% 25.08% 33.2% -59.33% 20.0% -100.0% 0.0% -100.0% -20.0%
Inventory $17.42K $26.02K $79.69K $90.97K $83.16K $20.00K $20.00K $10.00K $20.00K $20.00K $20.00K $20.00K
Prepaid Expenses
Receivables $26.59K $19.07K $80.00 $7.720K $10.20K $9.600K $11.34K $11.12K $6.150K $10.60K $10.00K $30.00K $0.00 $0.00 $0.00 $10.00K $40.00K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $245.2K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $35.46K $110.0K $74.24K $50.11K $16.38K $41.50K $315.9K $93.83K $97.12K $290.4K $550.0K $500.0K $30.00K $30.00K $50.00K $280.0K $420.0K
YoY Change -67.75% 48.1% 48.15% 205.92% -60.53% -86.86% 236.65% -3.39% -66.55% -47.21% 10.0% 1566.67% 0.0% -40.0% -82.14% -33.33%
Property, Plant & Equipment $120.00 $360.00 $680.00 $1.700K $3.280K $0.00 $0.00 $10.00K $10.00K $10.00K $20.00K $20.00K
YoY Change -66.67% -47.06% -60.0% -48.17% -100.0% 0.0% 0.0% -50.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $110.0K $0.00 $0.00 $0.00 $180.0K
YoY Change -100.0% -100.0%
Total Long-Term Assets $127.4K $136.8K $153.1K $150.1K $165.4K $178.9K $316.3K $245.8K $303.4K $355.7K $320.0K $250.0K $270.0K $240.0K $190.0K $90.00K $290.0K
YoY Change -6.89% -10.6% 1.95% -9.22% -7.55% -43.44% 28.7% -19.0% -14.7% 11.15% 28.0% -7.41% 12.5% 26.32% 111.11% -68.97%
Total Assets $162.9K $246.8K $227.3K $200.2K $181.8K $220.4K $632.2K $339.6K $400.5K $646.1K $870.0K $750.0K $300.0K $270.0K $240.0K $370.0K $710.0K
YoY Change
Accounts Payable $438.7K $1.202M $0.00 $7.620K $9.270K $10.49K $34.88K $25.96K $529.3K $0.00 $480.0K $640.0K $620.0K $640.0K $740.0K $470.0K $480.0K
YoY Change -63.5% -100.0% -17.8% -11.63% -69.93% 34.36% -95.09% -100.0% -25.0% 3.23% -3.13% -13.51% 57.45% -2.08%
Accrued Expenses $2.576M $1.956M $1.475M $1.021M $491.6K $1.169M $1.674M $759.8K $539.3K $348.1K $170.0K $30.00K $0.00 $10.00K $20.00K $20.00K $10.00K
YoY Change 31.69% 32.59% 44.42% 107.76% -57.96% -30.16% 120.38% 40.89% 54.91% 104.77% 466.67% -100.0% -50.0% 0.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $439.6K $433.6K $460.9K $604.5K $598.9K $2.816M $5.070M $4.854M $4.558M $4.228M $2.970M $1.690M $190.0K $360.0K $290.0K $120.0K $130.0K
YoY Change 1.38% -5.92% -23.76% 0.94% -78.73% -44.46% 4.44% 6.49% 7.81% 42.35% 75.74% 789.47% -47.22% 24.14% 141.67% -7.69%
Long-Term Debt Due $40.00K $40.00K $40.00K $220.0K $220.0K
YoY Change 0.0% 0.0% -81.82% 0.0%
Total Short-Term Liabilities $3.512M $3.645M $3.061M $2.719M $1.917M $4.940M $7.392M $6.448M $5.627M $4.997M $3.610M $2.370M $1.040M $1.310M $1.090M $670.0K $1.070M
YoY Change -3.64% 19.07% 12.59% 41.83% -61.19% -33.17% 14.64% 14.59% 12.61% 38.41% 52.32% 127.88% -20.61% 20.18% 62.69% -37.38%
Long-Term Debt $5.674M $3.242M $2.582M $1.936M $1.272M $0.00 $0.00 $0.00 $436.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 74.98% 25.59% 33.35% 52.22% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.674M $3.242M $2.582M $1.936M $1.272M $0.00 $0.00 $0.00 $436.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 74.98% 25.59% 33.35% 52.22% -100.0%
Total Liabilities $9.186M $6.887M $5.643M $4.655M $3.189M $4.940M $7.392M $6.448M $6.063M $4.997M $3.610M $2.370M $1.040M $1.310M $1.090M $670.0K $1.070M
YoY Change 33.37% 22.05% 21.22% 45.97% -35.44% -33.17% 14.64% 6.35% 21.33% 38.41% 52.32% 127.88% -20.61% 20.18% 62.69% -37.38%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Basic Shares Outstanding 4.540M shares 4.540M shares 4.540M shares
Diluted Shares Outstanding 4.540M shares 4.540M shares 4.540M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.6894 Million

About SKINVISIBLE, INC.

Skinvisible, Inc. is a pharmaceutical research company, which engages in the development of a patented polymer delivery system called Invisicare. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The firm is engaged in developing and patenting a polymer delivery system, Invisicare, and formulating over forty topical skin products. Its flagship product, Pivotal, is a patented polymer delivery system technology, Invisicare. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents. The company is also exploring opportunities in medical markets outside the dermatology market.

Industry: Pharmaceutical Preparations Peers: Youngevity International, Inc. ESTEE LAUDER COMPANIES INC Premier Product Group, Inc.